CXCL11 and neoplasm: In some of these examples, OVA expressing transfectants showed delayed tumor growth compared to the parental tumor cell line in vivo [23–25] as observed in our NY-BR-1 expressing model, although OVA expressing tumor models without effects on tumor outgrowth have been described as well [26].